Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates the body's production and release of growth hormone.

AREAS OF INTEREST

• Visceral Fat – Tesamorelin has been studied for its ability to reduce excess visceral abdominal fat in certain FDA-approved clinical circumstances.

• Growth Hormone Pathway – Stimulates endogenous growth hormone production through the GHRH pathway.

• Body Composition – Research has examined changes in abdominal fat and other body-composition measures.

• Metabolic Research – Tesamorelin continues to be investigated for its effects on metabolic and physiological pathways.

Important: Tesamorelin is an FDA-approved prescription drug for reducing excess abdominal fat in HIV-infected adults with lipodystrophy. It is not FDA-approved as a general weight-loss treatment.